Mitral valve repair for regurgitation has many advantages over mitral valve replacement. However, durability and reoperation after repair still remain major problems. We examined the outcome of mitral repair for @entity338 and analyzed several pre- and intraoperative factors to determine their impact on mortality and morbidity. METHODS: From January 1990 to December 2000, 69 @entity1 underwent mitral valve repair. The mean age was 52.8 years, and 82.6% were NYHA class III or IV. The causes of @entity339 were @entity63 in 32, rheumatic in 20 and degenerative in 17 @entity1 . Mitral valve repair was accomplished by Carpentier's techniques, Key commisuroplasty and ring implantation. RESULTS: There were 5 early and 6 late deaths in the @entity63 group and no early mortality and two late deaths in the mixed rheumatic and degenerative group. Seven @entity1 needed reoperation, 4 in the @entity63 group and 3 with @entity627 . Actuarial overall survival at 5 years was 100% in rheumatic, 86% in degenerative and 75% in @entity63 @entity1 . CONCLUSIONS: Mitral valve repair for @entity339 provides excellent results and long-term survival in rheumatic and @entity179 . The @entity63 etiology is the most important predictor for @entity204 and poor long term survival.

[Valve repair for XXXX --early and late results].

@entity1 :: ('9606', 'Species') :: ['patients'] @entity627 :: ('MESH:D012216', 'Disease') :: ['rheumatic disease'] @entity339 :: ('MESH:D008944', 'Disease') :: ['mitral valve disease', 'mitral regurgitation'] @entity63 :: ('MESH:D007511', 'Disease') :: ['ischemic'] @entity338 :: ('MESH:D011665', 'Disease') :: ['valve regurgitation'] @entity179 :: ('MESH:D019636', 'Disease') :: ['degenerative disease'] @entity204 :: ('MESH:D003643', 'Disease') :: ['early death']
@entity339 :: (MESH:D008944,Disease) :: ['mitral regurgitation']
